Mark J. Harrison
BSc(Hons), MSc, PhD
Dr. Mark Harrison joined the UBC Faculty of Pharmaceutical Sciences in August 2014 at the rank of assistant professor in sustainable health care, a position affiliated with the Collaboration for Outcomes Research and Evaluation (CORE). In this role, Dr. Harrison advances research, education, and practices in economic principles of health care sustainability with a focus on the role of pharmacy and pharmaceutical treatments in effecting change.
Dr. Harrison holds a first class honours degree in business and management sciences from the University of Bradford, UK, master's degree in epidemiology from the University of Edinburgh, and PhD from the University of Manchester. He began his research career with the Arthritis Research UK Epidemiology Unit at the University of Manchester in 2002, focusing on the variation in service provision and treatment outcomes in people with rheumatoid arthritis, drug safety and the evaluation of treatment strategies. Following the completion of his PhD, he worked at the Manchester Centre for Health Economics at the University of Manchester on a range of projects with academic, governmental, and industry partners. He also served as an adviser for the National Institute of Health Research (NIHR) Research Design Service for North West England. Dr. Harrison has a strong publication record with over 30 publications, 20 as lead author.
Dr. Harrison's main methodological and research interests lie in the measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions. His research focuses on the evaluation and re-evaluation of the type of healthcare that is provided, the point in the treatment pathway, and the way in which it is delivered. Before joining UBC, Dr. Harrison was involved with various initiatives at the University of Manchester, including evaluating the impact of incentive schemes to improve the quality of primary care on hospitalizations, patient-reported outcome measures to evaluate treatment outcomes, understanding treatment preferences, and the communication of risk and uncertainty to users of the health care system.
Health Economist, Health Technology Appraisal Committee, Health Technology Review, British Columbia Ministry of Health (2017)
Association of Faculties of Pharmacy of Canada New Investigator Research Award (2016)
University of British Columbia Certificate on Curriculum & Pedagogy in Higher Education: Faculty 3.Scholarship of Teaching and Learning (SoTL) Leadership Program (2016)
Faculty Instructional Workshop Certificate, Centre for Teaching, Learning and Technology,University of British Columbia (2015)
"OMERACT Fellow." Harrison MJ. OMERACT QALY Group (2008)
“Incentivizing the delivery of sustainable care of chronic diseases in Canada: case studies in musculoskeletal disease.” Harrison MJ (PI). $450,000. Michael Smith Foundation for Health Research, Scholar Award. 2017.
“A population-based analysis of multi-disciplinary rheumatology nursing care for people with complex rheumatic diseases.” Harrison MJ (PI). $271,397. CIHR Project Grant. 2016.
“Incentivizing the delivery of sustainable health care in Canada; applications in musculoskeletal disease.” Harrison MJ (PI). $180,000. The Arthritis Society. 2016.
“Preventing rheumatoid arthritis (Pre-RA): perspectives of people at risk and of rheumatologists on selected interventions.” Harrison MJ (Co-PI), Dr. M. Hudson (Co-PI). $82,933. Canadian Initiative for Outcomes in Rheumatology cAre (CIORA). 2015.
"Analysis of Accelerated Integrated Primary and Community Care (aIPCC) Data." McGrail K (PI), Law M, McGregor M, Berg S, Mitton C, Wong S, Bryan S, Harrison MJ (Co-I). $100,000. Michael Smith Foundation for Health Research. 2014–2015
“What are the impacts of billing codes for nurse management of complex rheumatic diseases in British Columbia? Let’s talk about it…" Knowledge Exchange, British Columbia Ministry of Health, Victoria BC. July 27th, 2017.
“Has the UK quality and outcomes framework improved outcomes for people with chronic diseases? Lessons for other health care systems.” Knowledge Exchange Forum. School of Public Health, University of Rwanda. October 19th, 2016.
“Were emergency admissions for ambulatory care sensitive conditions reduced in a UK pay for performance scheme?” Centre for Clinical Epidemiology and Evaluation (C2E2) Rounds, Vancouver Coastal Health Research Institute, Vancouver, BC. June 22nd, 2015.
“Sustainable healthcare – looking for the answers within the system." Rx&D Innovation and Healthcare Sustainability Policy Forum. Vancouver, BC. January 26, 2015.
"Does waiting time influence the effectiveness of surgery? Lessons from the NHS PROMS Project in the UK." Centre for Clinical Epidemiology and Evaluation (C2E2) Rounds, Vancouver Coastal Health Research Institute. Vancouver, BC. June 2013.